Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer.
Carsten NiederKristian S ImingenBård MannsåkerRosalba YobutaEllinor HauklandPublished in: Radiation oncology (London, England) (2020)
In order to reduce esophagitis after hypofractionated palliative treatment lower doses than those recommended in curative NSCLC settings are preferable. Besides esophageal dose, CRT is the main risk factor for esophagitis. Additional work is needed to confirm that steroids are able to modify the risk (or to rule out confounding effects of baseline variables not included in our database).
Keyphrases
- radiation therapy
- locally advanced
- palliative care
- brain metastases
- small cell lung cancer
- advanced cancer
- early stage
- combination therapy
- photodynamic therapy
- rectal cancer
- squamous cell carcinoma
- advanced non small cell lung cancer
- cancer therapy
- heart failure
- emergency department
- adverse drug
- replacement therapy
- left ventricular